CAS 127308-98-9: Zamifenacinfumarate
Description:Zamifenacin fumarate is a pharmaceutical compound primarily used as an anticholinergic agent for the treatment of overactive bladder and related urinary disorders. It functions by inhibiting the action of acetylcholine on muscarinic receptors, thereby reducing involuntary bladder contractions and increasing bladder capacity. The substance is characterized by its ability to selectively target specific receptor subtypes, which helps minimize side effects commonly associated with anticholinergic medications. Zamifenacin fumarate is typically administered orally and is known for its relatively favorable pharmacokinetic profile, including good absorption and metabolism. Its efficacy and safety profile have been evaluated in clinical studies, demonstrating its potential benefits in managing urinary symptoms. As with many medications, it may have side effects, including dry mouth, constipation, and dizziness, which are common to anticholinergic drugs. Overall, Zamifenacin fumarate represents a valuable option in the therapeutic landscape for patients suffering from urinary incontinence and related conditions.
Formula:C31H33NO7
InChI:InChI=1/C27H29NO3.C4H4O4/c1-3-8-22(9-4-1)27(23-10-5-2-6-11-23)31-24-12-7-16-28(19-24)17-15-21-13-14-25-26(18-21)30-20-29-25;5-3(6)1-2-4(7)8/h1-6,8-11,13-14,18,24,27H,7,12,15-17,19-20H2;1-2H,(H,5,6)(H,7,8)/b;2-1+/t24-;/m1./s1